Straumann 2025 Annual Report: Revenue of Approximately 22.6 Billion RMB, Q4 Asia-Pacific Revenue Declines 12.8% Due to Impact from China Region

Image Source: Straumann 2025 Performance Report

2025 Revenue CHF 2.605 Billion / Core EBIT Margin 25.2% / Organic Revenue in China Declined 12.8%

DentalGoodNews｜Global dental giant Straumann Group recently released its 2025 performance report. The report shows that the Group's full-year revenue reached CHF 2.605 billion (approximately RMB 22.610 billion), with an organic growth rate of 8.9%. Fourth-quarter revenue was CHF 655 million (approximately RMB 5.685 billion), with organic growth of 7.0%, demonstrating resilient growth in a complex market environment.

Image Source: Straumann 2025 Performance Report

In terms of profitability, Straumann's 2025 core EBIT (Earnings Before Interest and Taxes) was CHF 655 million (approximately RMB 5.685 billion), with a core EBIT margin of 25.2%. Calculated at constant 2024 exchange rates, the core EBIT margin reached 26.5%, at the high end of the company's previous guidance. Furthermore, the Group's full-year core net profit was CHF 478 million, with basic earnings per share (EPS) of CHF 2.99 (approximately RMB 25.95). Based on solid financial performance, the Board of Directors proposed a dividend of CHF 1.00 per share (approximately RMB 8.68), a 5% increase compared to the previous year.

Image Source: Straumann 2025 Performance Report

Regarding regional performance, the Asia-Pacific (APAC) region, which includes China, was impacted by procurement cycles. Fourth-quarter APAC revenue was CHF 124 million (approximately RMB 1.076 billion), with an organic decline of 12.8%, primarily due to slowed patient flow in China in anticipation of the second round of Dental Implant Volume-Based Procurement (VBP) (VBP 2.0) and distributor inventory reduction. However, the APAC market excluding China performed strongly, achieving full-year organic growth of 10.2%. In contrast, the EMEA (Europe, Middle East, and Africa) region achieved 15.3% organic growth in the fourth quarter, mainly driven by strong demand in Germany, Austria, and the Benelux region.

In terms of product and strategic execution, Straumann continues to increase market share through digital transformation. In 2025, the Group successfully launched the iEXCEL implant system globally and introduced the SIRIOS X3 intraoral scanner and the Straumann AXS cloud-based digital platform. In the field of Orthodontics, substantial progress has been made in the transformation of the orthodontic business through the strategic partnership between ClearCorrect and Smartee. According to a previous report by DGN, Straumann had already accelerated its layout in the digital orthodontic ecosystem through this partnership in the third quarter of 2025.

Image Source: Straumann 2025 Performance Report

Regarding cash flow and asset structure, Straumann's 2025 net cash flow from operating activities remained robust. Despite impacts from currency fluctuations and taxes, free cash flow still reached CHF 290 million (approximately RMB 2.517 billion). As of the end of 2025, the Group's total global workforce was 11,821, remaining essentially flat compared to the end of the previous year.

For 2026, the Straumann Group expects full-year organic revenue to achieve high single-digit growth. Based on constant 2025 exchange rates, the core EBIT margin is projected to further improve by 30 to 60 basis points.